Northwestern Mutual Wealth Management
LPCN icon

Northwestern Mutual Wealth Management’s Lipocine LPCN Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-466
Closed -$2.35K – 3440
2023
Q2 		$2.35K Buy
+466
New +$2.19K ﹤0.01% 2961
2023
Q1 		– Sell
-3
Closed -$20 – 3502
2022
Q4 		$20 Buy
+3
New +$22 ﹤0.01% 3277

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northwestern Mutual Wealth Management's LPCN Position: Q3 2023 in Review

Northwestern Mutual Wealth Management sold out of Lipocine (LPCN) in Q3 2023, closing a stake of 466 shares — an estimated $2.35K sold.

Northwestern Mutual Wealth Management first reported a position in LPCN in Q4 2022 and held it in 2 quarters. The position peaked at $2.35K in Q2 2023. 21 funds tracked by Wall St. Rank hold LPCN as of Q3 2023.

  • Northwestern Mutual Wealth Management reported no remaining Lipocine position as of Q3 2023 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 466 Lipocine shares in Q3 2023, an estimated $2.35K.
  • Northwestern Mutual Wealth Management first reported a position in Lipocine in Q4 2022 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's Lipocine position peaked at $2.35K in Q2 2023.
  • 21 funds tracked by Wall St. Rank held Lipocine as of Q3 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.